Brachytherapy for uterine cervix-limited acute myeloid leukemia relapse

Acute myeloid leukemia (AML) may extend to extra-medullary sites at diagnosis or at relapse, either isolated or associated with bone marrow disease. Granulocytic sarcoma of uterine cervix is rare, and there is no established treatment for this disease. Two cases of uterine cervix-limited AML relapse...

Descripción completa

Detalles Bibliográficos
Autores principales: Beziat, Guillaume, Tavitian, Suzanne, Arnaud, Francois-Xavier, Izar, Françoise, Attal, Justine, Borel, Cécile, Recher, Christian, Ducassou, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924153/
https://www.ncbi.nlm.nih.gov/pubmed/36819473
http://dx.doi.org/10.5114/jcb.2022.123980
Descripción
Sumario:Acute myeloid leukemia (AML) may extend to extra-medullary sites at diagnosis or at relapse, either isolated or associated with bone marrow disease. Granulocytic sarcoma of uterine cervix is rare, and there is no established treatment for this disease. Two cases of uterine cervix-limited AML relapse showed that brachytherapy may be an effective therapeutic option in this setting along with chemotherapy, with good tolerance.

Ejemplares similares